Axonics Therapy, also referred to as Sacral Neuromodulation, is an advanced bladder and bowel control treatment that can help reduce the symptoms of overactive bladder, bowel incontinence, and urinary retention. The therapy works by helping restore normal communication between your brain and your bladder and/or bowel.
Axonics Sacral Neuromodulation Therapy provides gentle stimulation to the nerves that control the bladder and bowel. The stimulation can help restore normal communication between the brain and the bladder and/or bowel, which can result in an improvement of your overactive bladder, bowel incontinence, and urinary retention symptoms.
Axonics Therapy is not a cure, but it is a long-term therapy that may provide significant relief of your symptoms.
Axonics Therapy is a safe and effective treatment, indicated for people suffering from overactive bladder, bowel incontinence, and/or urinary retention who have not found relief with previous treatments. Seek advice from your doctor to see whether Axonics Therapy is right for you.
Axonics Sacral Neuromodulation Therapy is a long-lasting treatment option for overactive bladder, bowel incontinence, and urinary retention. Sacral Neuromodulation is the only advanced therapy shown in a clinical study to produce greater symptom reductions and improvements in quality of life than oral medication. Another advantage is that there is a 14-day trial period to ensure Axonics Therapy is right for you. At the end of the trial period, you and your doctor can decide what your next treatment steps are.
Axonics Therapy provides the choice between rechargeable or recharge-free systems. The Axonics F15 Recharge-Free System lasts for 10 to 20 years. The Axonics R20 Rechargeable System is designed to last 20 years or more.
Most insurances cover this therapy, including Medicare. Speak with the staff at your doctor’s office to learn more about your insurance coverage.
Monday-Friday (excluding holidays)
9:00 AM – 9:00 PM Eastern Time
For any medical questions, please call your doctor.